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Abstract Many studies have demonstrated the asso-
ciation between telomere length in mitotic cells and
aging, but the relationship between telomere length in
post-mitotic cells and aging in human populations has
remained largely unclear. In this study, we assessed
the dynamics of telomere length (terminal restriction
fragment length—TRF) in normal pituitary glands
obtained at autopsy from 65 patients aged between 0
and 100 years. The initial length (the value for
neonatal pituitary) was 14.2±1.1 kbp (mean of the
median TRF value±SD), being the longest among
those for other systemic organs. The annual telomere
reduction rates for pituitary (21 bp) were equivalent to
or below the lowest values for various cells and
tissues. Hence, comparison of TRF lengths among
organs revealed that the pituitary gland retained
longer telomeres than most other organs throughout
life. The median TRF value showed a significant
decrease between newborns and the 61–75 age group,
but then leveled off or increased slightly in advanced
age groups. These data indicate that innate telomere
length is highly conserved in the pituitary and suggest
that pituitary telomere length provides a good basic
indicator for studies of telomere biology.
Keywords Telomere . Terminal restriction fragment
(TRF) . Pituitary gland . Human aging . Cell
proliferation
Introduction
Telomeric DNA protects chromosomes against degen-
eration, reconstruction, fusion, and loss (Blackburn
1991). With the exception of immortal, carcinoma-
tous, and germ cells, the telomeres of all human cells
become shortened at every cell division due to the
end-replication problem (Olovnikov 1971, 1996;
Watson 1972; Levy et al. 1992) and trimming by
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nucleases (Verdun and Karlseder 2007). Indeed,
accumulated data indicate that telomeric repeats of
DNA sequences at chromosome ends are shortened
by 33–120 bp with each cell division in human
fibroblasts (Harley et al. 1990) and lymphocytes
(Vaziri et al. 1993) in vitro, and that telomeres in
most human systemic organs/tissues also shorten by
25–100 bp annually in vivo (Takubo et al. 2002; Ishii
et al. 2006). In the case of post-mitotic cells, the
situation is quite different. When we analyzed a
typical organ composed of post-mitotic cells, the
cerebrum, we found that innate telomere lengths were
very well maintained and associated with longevity
(Nakamura et al. 2007).
The telomere hypothesis of cellular aging suggests
that when telomere shortening (on a particular
chromosome) reaches a critical level, the chromosome
may become unstable and the cells stop dividing
(Harley et al. 1990; Allsopp et al. 1992). This
hypothesis has prevailed as one of the most feasible
for explaining not only the cause of cellular aging but
also aging of individuals. Indeed, Cawthon et al.
found that individuals with shorter telomeres of blood
had a high mortality rate due to heart disease and
infectious disease, thus providing cutting-edge data in
this field (Cawthon et al. 2003). We have also
reported unequivocal data to support the hypothesis
that longer telomeres can protect the genome from
instability (a major cause of carcinogenesis) and
appear to have a relationship to longevity (Nakamura
et al. 2007). Although reports regarding the relation-
ship between telomere length and human aging have
accumulated, the dynamics of human telomere status
in vivo, especially in post-mitotic cells, remain largely
unexplored.
In the present study, we measured the terminal
restriction fragment (TRF) length of HinfI- or RsaI-
digested genomic DNA from human pituitary glands,
and investigated the population dynamics of telomere
status and the relationship between telomere length
and aging. Since the pituitary gland is one of the
human organs that shows the highest degree of
preservation during aging (Sawabe et al. 2006) and
scarcely shows age-related changes, for example
lymphocyte infiltration and fibrosis, it is particularly
intriguing from the viewpoint of telomere dynamics.
For measurement of telomere length in most of our
previous studies, we have been using the peak values
demonstrated on densitometric profiles obtained by
Southern blotting of TRF (Hastie et al. 1990).
Although many methods for measurement of telomere
length have since been introduced (including PCR
and fluorescence in situ hybridization), TRF-based
analyses have been considered to represent a gold
standard in this field, and have been enhanced by the
introduction of many innovative developments in
both hardware and software. Recently, we have
adopted a software package “Telometric”, which
shows robust reproducibility, and obtained prelimi-
nary data indicating that the peak values obtained
using the original method are comparable with the
median values calculated using “Telometric”. In order
to derive confirmatory data for comparison with
archived data obtained using different methods, we
further tried to assess the relationship between the
peak and the median values, and between the mean
and the median values of telomere length.
Materials and methods
Samples from autopsied patients
Pituitary tissue samples from 65 autopsied patients
(37 males and 28 females) aged between 0 and
100 years were analyzed by Southern blotting. The
patients included nine neonates, four infants (0.3–
0.8 years), one young adult (22 years), one individual
in his forties, four in their sixties, 14 in their
seventies, 15 in their eighties, 15 in their nineties,
and two centenarians (each aged 100 years). Among
them, pancreas tissue from 14 patients and heart tissue
from four patients were also sampled and analyzed
(Supplementary material, Table S1).
Pituitary samples from another set of autopsied
patients, comprising 17 males and 13 females aged
between 0 and 100 years, were analyzed for the
proliferative potential of their component cells by
immunostaining for the DNA synthesis phase-specific
antigen Ki-67 (Supplementary material, Table S2).
The autopsies were performed at Tokyo Metropolitan
Geriatric Medical Center, Saitama Children’s Medical
Center, and the Japanese Red Cross Medical Center.
None of the case histories or examination findings
suggested pituitary gland-related disease. All samples
were stored at −80°C until use. The Tokyo Metropol-
itan Institute of Gerontology Ethics Committee
approved the study protocol. Family members of all
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the autopsied individuals provided signed written
consent for use of the materials for scientific research,
including DNA analysis.
Histological and immunohistochemical examination
The sampled pituitary glands were examined at autopsy
by specialists in anatomical and surgical pathology (M.
S., T.A., M.F., H.K., and K.T.), and samples exhibiting
autolysis or marked degeneration were excluded.
To assess the proliferation status of the component
cells of the pituitary gland, we performed immunos-
taining of age-matched pituitary gland samples with
anti-Ki-67 antibody (monoclonal antibody—MIB-1;
Dako Cytomation, Glostrup, Denmark) by the
Polymer-Immuno Complex method [ENVISION+/
HRP (DAB); Dako Japan]. Antibody-stained sections
were examined quantitatively by two pathologists (N.
I., J.A.) who estimated the numbers (%) of cells
showing positive staining.
Preparation of genomic DNA
Genomic DNA was prepared by the standard method.
Briefly, the samples were incubated with 2 μg/ml
proteinase K and 0.8% sodium dodecyl sulfate (SDS)
in lysis buffer (10 mM Tris–HCl, 50 mM NaCl,
50 mM EDTA, 27% sucrose, and distilled water),
followed by repeated phenol–chloroform extraction.
To isolate intact high molecular weight DNA, we
performed all the procedures as gently as possible.
The extracted genomic DNA was tested for its
quality using a biased sinusoidal field gel electropho-
resis method (Schwartz and Cantor 1984) with the
Genofield system (ATTO, Tokyo, Japan). All of the
DNA samples showed smears of more than 100 kbp,
and thus qualified for subsequent Southern blot
analyses.
Measurement of telomere (TRF) lengths
The procedures used for Southern blot analysis have
been described previously in detail (Takubo et al.
1999; Nakamura et al. 2002). In previous experi-
ments, we had used HinfI, which has been the
restriction enzyme employed most universally. In
addition, we sometimes used RsaI, which is also
widely adopted in this field and is stochastically and
empirically known to cut eukaryotic genomes more
frequently than HinfI (see the New England Biolabs
technical support manual). We expected that RsaI-
digested TRF would have a shorter subtelomeric
stretch than HinfI-digested TRF, and that this would
provide further confirmation. Hence, in this study, we
used two restriction enzymes: HinfI and RsaI (Roche
Biochemicals, Germany). Briefly, aliquots of DNA
were digested with a restriction enzyme, and complete
cleavage was confirmed. All of the DNA samples
were analyzed using HinfI, and 44 were analyzed
using RsaI because of shortage of available DNA
samples. We performed electrophoresis repeatedly,
two to four times for each sample. DNA fragments
were then transferred to nylon membranes (Hybond-N
+, Amersham, UK) and subjected to hybridization
with a (TTAGGG)4 probe that had been labeled with
[γ-32P]ATP (Amersham). After drying, the mem-
branes were exposed to Imaging Plates (Fuji Photo
Film, Tokyo, Japan), and analyzed with a Mac BAS-
2500 image analyzer (Fuji Photo Film) using the
programs Image Reader (version 1.1, Fuji Photo
Film) and Mac Bas (version 2.4, Fuji Photo Film).
We obtained representative values for TRF length
using the software package Telometric (Grant et al.
2001), and calculated the median and the mean values
for the TRF smear signals. At this stage, two samples
were disqualified due to suspected degradation of the
DNA and were omitted from further study, leaving a
final total of 63 cases that were analyzed. We also
determined the position giving the peak intensity from
the profile of the TRF signal intensity by our
conventional method, as described previously (Hastie
et al. 1990; Takubo et al. 1999). The data, and mean
values for each sample, are shown in Supplementary
material, Table S1.
Statistical analysis
Statistical analyses were performed with StatView
software version 5.0 (SAS Institute Inc.). Differences
in mean values were assessed for significance by
analysis of variance (one-factor factorial ANOVA) and
follow-up post hoc tests (Tukey–Kramer test and
Bonferroni/Dunn test) among four age groups: 0–
1 years, 61–75 years, 76–90 years, and >90 years.
Correlation significances were assessed with Fisher’s
test. Categorical variables were analyzed by Pearson’s
chi-squared test. To analyze the relationships between
the median values and the peak values of TRF, the
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median values and mean values of TRF, and the
relationships of the pituitary to other organs, we applied
a multiple regression model.
Results
Histological and immunohistochemical characteristics
of pituitary glands
As contamination with other cell types is always a
problem in studies of telomere length in human
tissues or organs (Greider 1996; Takubo et al. 1999),
as opposed to measurements using cultured cell lines,
we checked the histological characteristics of the
pituitary samples. We analyzed the pituitary en bloc
for neonates and infants, and a lateral portion of the
gland for adults.
A survey of age-matched samples indicated that
the major part of each sample was composed of the
anterior lobe (adenohypophysis) (Lopes et al. 2007).
None of the age-matched samples exhibited marked
inflammatory cell infiltration, but small patches of
mild fibrosis were evident in a very small number of
specimens from elderly individuals. These findings
and our previous observations (Sawabe et al. 2006)
suggested that the cells evaluated for pituitary TRF
were endocrine-competent cells. Immunostaining for
Ki-67 showed that positive cells were more prevalent
(5–10%) in fetuses at 20 weeks of gestation, present
at rates of 0.2–0.5% in neonates and less than 0.2% in
infants, and negative in adults and the elderly
(Supplementary materials, Table S2, Fig. S1). These
data reflected the rapid proliferation of the pituitary
towards the end of gestation.
Representative TRF lengths in pituitary glands
Representative TRF images obtained by Southern blot
analysis of HinfI- or RsaI-digested genomic DNA
derived from the neonatal pituitary glands are shown
in Fig. 1a (lanes 1–6). Due to sample quantity
limitation, the number of cases analyzed after RsaI
digestion was reduced to 40. The median values
(determined using Telometric software) for TRF
signals derived from HinfI- and RsaI-digested pitui-
tary ranged from 9.2 to 15.8 kbp (12.6±1.5 kbp;
mean±SD) and from 9.2 to 15.3 kbp (11.9±1.4 kbp;
mean±SD), respectively. The relationship between
median values of TRF lengths for Hinf1-digested and
RsaI-digested samples was examined by scatter plot
analysis, and this demonstrated a robust correlation
between the paired values (slope=0.95, p<0.0001;
Supplementary material, Fig. S2).
Annual rate of reduction of telomere length
in pituitary glands
The median value of the HinfI-digested TRF lengths
for all 63 subjects was plotted as a function of age
(Fig. 2), and this yielded a regression line indicating
that the average annual rate of telomere shortening
was 21 bp (p<0.001).
The RsaI-digested samples were also analyzed in the
same way. The average annual rate of reduction of the
median value was 7.5 bp (p=0.31). (Supplementary
material, Fig. S3).
Telomere length differences between age groups
Since the median TRF values for HinfI-digested
sample sets from neonates were greater than those
from elderly individuals, we divided the samples into
four age groups (0–1, 61–75, 76–90, and >90 years)
and assessed the data among the groups by ANOVA
and post hoc tests (mean values±SD are shown in
Fig. 3). The values were greatest for the neonate–infant
samples, and smallest for the 61–75-year age group.
Comparison of neonates–infants with other age groups
for HinfI-digested samples showed that telomere (TRF
median) shortening was statistically significant in each
case (0–1 vs. 61–75, 0–1 vs. 76–90, 0–1 vs. >90).
There were no significant differences between any of
the combinations among the three age groups (Fig. 3).
The RsaI-digested samples were also categorized
and analyzed in the same way. The mean value for
neonates was also the greatest and that for the 61–75-
year age group was the smallest. The telomere
shortening profile for the RsaI digests resembled that
for HinfI digests, but showed no significant differ-
ences among any of the groups (Supplementary
material, Fig. S4).
Reassessment of telomere length dynamics
in the older population
Since these inter-age-group analyses suggested that
the median TRF lengths in pituitary glands were
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preserved in the elderly, we reassessed the scatter plot
data for individuals in their sixties and older (omitting
neonates, infants, and young adults) (dashed line in
Fig. 2). The representative values (median TRF values
for HinfI-digested materials) provided regression lines
with positive slope values [18(bp/year)]. The represen-
tative values for RsaI-digested materials also provided
regression lines with positive slope values (Supple-
mentary material, dashed line in Fig. S3).
Differences in telomere length
among the three different methods
To assess the present data against archived data
obtained using a different method, we also determined
the position giving the peak intensity from the profile
of the TRF signal intensity obtained by the conven-
tional method, as described previously (Hastie et al.
y = -0.021x + 13.9,  p < 0.0001
y = 0.016x + 10.8,   p = 0.330
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Fig. 2 Telomere dynamics with aging. First scatter plot analysis
of representative TRF values obtained from HinfI-digested
samples as a function of donor age over the full range yields a
decreasing regression line for each representative [median values;
filled circles (n=63), solid line]. Second scatter plot analysis of
the TRF values for individuals aged 60 years and older yields an
increasing regression line for each representative [median values;
filled circles (n=48), dashed line]
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Fig. 1 Southern blot analysis of terminal restriction fragments
(TRF) from pituitary and systemic organs. a Representative TRF
signals of the pituitary samples obtained from three neonates
(case #8, 38 weeks of gestation—lanes 1 and 2; case#4, 35 weeks
of gestation—lanes 3 and 4; case #5, 36 weeks of gestation—
lanes 5 and 6). The restriction enzyme employed was either HinfI
(lanes 1, 3, 5) or RsaI (lanes 2, 4, 6). The median values (kbp)
for the signals were 14.0, 13.3, 13.4, 12.9, 14.4, and 13.7,
respectively. b Representative HinfI-digested TRF signals
obtained from a premature neonate (case #1, 21 weeks of
gestation; 1 heart, 2 skin, 3 scalp, 4 adrenal gland, 5 liver, 6
pituitary gland). The median values (kbp) for the signals were
14.8, 13.2, 13.0, 14.6, 15.1, and 15.4, respectively. c Represen-
tative HinfI-digested TRF signals obtained from a centenarian
(case #62; 1 cerebral gray matter, 2 cerebral white matter, 3 heart,
4 liver, 5 kidney, 6 adrenal gland, 7 pancreas, 8 thyroid, 9 tongue,
10 skin, 11 scalp, 12 muscle, 13 pituitary gland). The median
values (kbp) for the signals were 8.7, 7.9, 9.2, 6.6, 8.0, 8.1, 7.5,
8.5, 7.8, 7.4, 7.8, 8.5, and 9.1, respectively. Size marker (λ/
HindIII) positions are indicated on the left. The mean values (the
median values calculated using the Telometric software package,
and the peak values of signal intensity) of repeated experiments
are summarized in the supplementary table (Supplementary
material, Table S1)
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1990; Takubo et al. 1999), and compared it with the
data determined from the median values (Supplemen-
tary material, Table S1). The median values (deter-
mined using the Telometric software package) and the
peak values for TRF signals derived from HinfI-
digested pituitary ranged from 9.2 to 15.8 kbp and
from 8.3 to 18.2 kbp, respectively. Scatter plot
analysis demonstrated a robust relationship between
the median and the peak values (Fig. 4), and the
regression lines obtained from the median values and
from the peak values showed a close resemblance
(Fig. 5). To further investigate the relationship
between the median and the peak values, we
performed multiple regression analysis. This indicated
that the group coefficient (β2) of the median versus
peak values was very small (0.043 kbp) and were not
statistically significant (p=0.90) (Fig. 5).
We also investigated the relationship between the
median and the mean values using the same multiple
regression analysis. This demonstrated that the differ-
ence between the median versus the mean values was
1.2 kbp and robustly significant (p<0.0001) (Supple-
mentary material, Fig.S5).
Comparison of TRF length between pituitary gland
and other organs
We analyzed TRF lengths for both the pituitary gland
and pancreas from 14 patients (data are shown in
Table S1). TRF length for the pituitary gland was
greater (by more than 0.5 kbp) than that for the
pancreas in 10 cases, and the values for the pituitary
and pancreas were almost the same (the difference
being less than 0.4 kbp) in four cases (including one
premature neonate and one 0.3-year infant). We also
analyzed TRF lengths for both the pituitary gland and
heart in four individuals (data are shown in Table S1).
TRF length for the pituitary was greater (by more than
0.5 kbp) than that for the heart in two cases, and the
values were almost the same (the difference being less
than 0.4 kbp) in two cases.
In two individuals, we then analyzed the TRF
lengths for systemic organs in addition to the pituitary.
Representative TRF images of HinfI-digested genomic
DNA derived from the systemic organs of an individ-
ual infant are shown in Fig. 1b (lanes 1–6). Median
TRF values were within the range 13.0–15.4 kbp, and
the pituitary gland had the largest median value. Other
representative TRF images derived from systemic
organs of a centenarian individual are shown in
y = 1.2x - 2.1







0 5 10 15 20
























Fig. 4 Relationship between the peak values of TRF signal
intensity and the median values calculated using the Telometric
software package. Scatter plot analysis of TRF lengths for
HinfI-digested samples provides a robust correlation between
the peak values (y-axis) and the median values (x-axis),
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Fig. 3 Comparison of TRF lengths for the pituitary gland in the
four age groups: 0–1, 61–75, 76–90, and >90 years. Mean values
(±SD) of individual median TRF length for HinfI-digested
samples from the four age groups were calculated and compared
using ANOVA and post hoc tests. The mean value (±SD) for
neonates and infants (n=13) was 14.2±1.1 kbp. The values for
the older age groups were 11.6±1.5 kbp for subjects aged 61–
75 years (n=14), 12.4±1.3 kbp for those aged 76–90 years (n=
17), and 12.3±1.3 kbp for those aged >90 years (n=17, including
two centenarians). The p value by ANOVAwas <0.0001. Each of
the differences between the neonates–infants versus the three
older age groups was significant by both Tukey–Kramer test and
Bonferroni–Dunn test (significant difference, p<0.0083, is
indicated by asterisks, and p values presented in parentheses
were calculated by the latter test): 61–75 (p<0.0001), 76–90 (p=
0.0007), and >90 (p=0.0002), respectively. However, there were
no significant differences between any of the combinations
among the other three age groups
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Fig. 1c (lanes 1–13). Median TRF values for individual
organs were within the range 6.6–11.3 kbp, and—after
the heart—the pituitary gland had the second largest
value. These data strongly suggested that the TRF
value for the pituitary might be the highest among the
systemic organs examined.
We then compared the data derived from pituitary
samples with our previous data for in vivo telomere
attrition in systemic organs, including the liver, kidney,
spleen, brain, heart (Takubo et al. 2002), pancreas (Ishii
et al. 2006), and gray matter and white matter of the
cerebrum (Nakamura et al. 2007) (shown in Supple-
mentary material, Fig.S7). These comparisons demon-
strated that both the regression lines of the TRF values
(the median and peak values) for the pituitary gland
were higher than those for other organs at all ages
between neonates and centenarians except that for gray
matter of the cerebrum in individuals over 90 years
old. To further investigate the relationship between the
TRF values for the pituitary and those of other organs,
we performed multiple regression analysis (see the
legend for Fig.S7). The probabilities of differences
determined by this analysis were as follows: pituitary
versus cerebral gray matter, p=0.0062; pituitary versus
cerebral white matter, p<0.001; and pituitary versus
heart, p<0.0001. The group coefficient (β2) for
pituitary versus cerebral gray matter was 0.39 kbp
(p=0.28), that for pituitary versus cerebral white matter
was 1.45 kbp (p<0.01), and that for pituitary versus
heart was 0.82 kbp (p=0.030). The regression line of
cerebral cortex located center of regression lines of
cerebral gray and white matter, and under of that of
heart. These data demonstrated that the TRF for the
pituitary was statistically longest among the TRF
values for the systemic organs examined except
cerebral gray matter.
Comparison of cancer death rates between older age
group
The studied individuals were divided into two groups
according to the major cause(s) of death diagnosed at
autopsy: patients who had died as a result of carcinomas
and hematopoietic malignancies, and patients who died
of other diseases (see Supplementary material, Table S1,
Fig. S6). The latter category included curatively treated
cancer patients and patients with latent cancers who
had died of other diseases. The cancer death rates for
individuals in the 61–75-, 76–90-, and 90–100-year
age groups were 79% (11 cancer deaths among 14
cases), 35% (6/17), and 12% (2/17), respectively
(Fig. 6). Statistical analysis revealed a significantly
lower rate of cancer-related death in individuals aged
76–90 (p=0.016) and 91–100 (p=0.0002) years versus
those aged 61–75 years. The malignancies that were
considered to have been the direct cause of death were,
in order of incidence: lung cancer (5), gastric cancer
(3), gallbladder cancer (2), esophageal cancer (2),
pancreatic cancer (2), leukemia (acute myelogenous
leukemia) (2), colon cancer (1), hepatocellular carci-
noma (1), and duodenal cancer (1). The proportion of
those who died of cancer was reasonably consistent
with that for the Japanese population as a whole
(Statistics and Information Department, Ministry’s
Secretariat, Ministry of Health, Labour and Welfare
Japan 2006). For the studied individuals overall, the
mean of the median value of TRF length for those who
had died of cancer (n=19—12.2±1.5 kbp) was almost
the same as that for those who had died of other
diseases (n=30—12.2±1.4 kbp).
Discussion
To date, more than 30 human systemic organs or tissues
have been subjected to telomere length analysis using
various methods. Although many groups have con-
Densitometric Peak: y = -0.024x + 14.1, R2 = 0.126, p = 0.0042
Telometric Median: y = -0.021x + 13.9, R2 = 0.233, p < 0.0001
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Fig. 5 Comparison between two scatter plot analyses: one
regression line was obtained from the median values of TRF as
a function of donor age (see Fig. 2), and the other was obtained
from the peak values of TRF as a function of donor age. To
analyze statistically the relationship between the median values
and the peak values of pituitary TRF, we applied a multiple
regression model that related Y (TRF length) to X1 (age) and X2
(group), given that the value for the median group was 1 and
that for the peak group was 0: Y=β0+β1X1(age)+β2X2(group).
The group coefficient (β2) of the median versus peak values
was −0.043 kbp (p=0.90)
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ducted studies, including our own, no telomere analysis
of the human pituitary gland has yet been reported. In
the present study, we investigated the dynamics of
telomere (TRF) length in the human pituitary gland.
Sawabe et al. have reported age-associated changes
in human organ weights based on 1,615 consecutive
autopsies conducted on patients aged 60–109 years at
our institution (Tokyo Metropolitan Geriatric Hospital)
(2006). The investigated organs included the brain,
heart, lung, liver, kidney, spleen, hypophysis (pituitary
gland), thyroid, and adrenal gland. This valuable data
source revealed that the pituitary had several notable
characteristics from the viewpoint of aging. First, the
gross size of the pituitary was generally better preserved
during aging than any other organ and remained almost
constant up to 80 years of age. Second, the pituitary
gland demonstrated no age-related changes in terms of
histology; even in extremely old individuals, hardly any
age-related inflammatory cell infiltration or degenera-
tion was evident, with only mild fibrosis. Third, the
pituitary gland plays a pivotal physiological role in
hormonal homeostasis via the hypothalamus–pituitary
axis. These three features, and the relatively rapid
organogenesis of the pituitary indicated by Ki-67
immunostaining (see Supplementary materials,
Table S2, Fig. S1), appeared to suggest that this organ
might have unique characteristics in terms of telomere
status, i.e., (1) the initial TRF length (the value for
neonatal pituitary) was 14.2±1.1 kbp (mean±SD),
being highest among those for other systemic organs,
and (2) intrinsic telomere length is well conserved
throughout life. In fact, the TRF length for the pituitary
gland was one of the longest in several individuals
whose systemic organs were analyzed (Fig. 1, see also
Takubo et al. 2002).
Many studies of telomere shortening with age have
focused on a variety of human systemic tissues (Ishii et
al. 2006). Many different methods and different
representative values have been used in those studies,
and this has made it difficult to achieve an integrated
understanding of the huge amount of archived data for
TRF length. In this study, we have re-evaluated these
differences based on our own data and tried to provide
practical clues for utilizing such archived data. Our
data suggested that the peak and median values of TRF
could be compared under certain circumstances.
Furthermore, although the median values of TRF were
usually less than mean values due to the skewed
distribution of TRF, our study also suggested that the
median and mean values were also comparable at least
in terms of the annual attrition rates derived from these
two different representative values.
The reported annual telomere reduction rates for
various cells and tissues were within 25–100 bp per year.
Our present results show that the values for pituitary
(21 bp) were equivalent to, or below, the lowest part of
this range, and slightly larger than those for heart and
brain (gray matter) (Takubo et al. 2002; Nakamura et al.
2007; see also legend of Fig. S7). This feature can be
explained in terms of the cell proliferation dynamics
for this organ: that is, marked proliferation occurs at
the early fetal stage up to 20 weeks of gestation, and
then suddenly stops almost completely at around
37 weeks. After birth, the pituitary slowly grows and
matures, and thereafter is very well preserved through-
out life, without only minimal age-related changes. On
the other hand, Frenck et al. (1998) have reported rapid
loss of telomere length in peripheral blood cells of
young individuals and a much slower rate of attrition
in older adults. A longitudinal study of baboon
hematopoietic cells has further confirmed this phe-
nomenon (Bearlocher et al. 2007). These data matched
those that were theoretically expected and defined the
phenomenological aspect of telomere length regulation,






























Fig. 6 Cancer death rate in older Japanese age groups. The
older patients were divided into three age groups (61–75, 76–
90, and >90 years). The cancer death rate was 79% for subjects
aged 61–75 years (n=11/14), 35% for those aged 76–90 years
(n=6/17), and 12% for those aged >90 years (n=2/17,
including two centenarians). Each of the differences between
the 61–75-year group versus the two older age groups was
significant by Pearson’s chi-squared test (significant difference,
p<0.05, is indicated by asterisks, and p values are presented in
parentheses): 76–90 years (p=0.016) and >90 years (p=
0.0002), respectively
802 AGE (2012) 34:795–804
With regard to the in vivo telomere dynamics of post-
mitotic cells, we have previously reported the age-related
telomere length dynamics in the brain, a typical organ
composed mainly of post-mitotic cells. Telomere lengths
decreased only slightly up to the 70–79-year age range,
but then inversely increased in individuals of more
advanced age. Thus, the 90–100-year age group pos-
sessed significantly longer telomeres than individuals in
their seventies (Nakamura et al. 2007). The present study
demonstrated a pattern of telomere length dynamics in
the pituitary similar to that of the cerebrum.
Cawthon et al. (2003) reported that individuals
with shorter telomeres in blood had a high mortality
rate due to heart disease and infectious disease, and
speculated that such individuals might have increased
rates of mortality due to many of the diseases
typically associated with aging. This was based upon
the notion that telomere lengths in blood cells accord
with those in other tissues (Friedrich et al. 2000;
Saretzki and von Zglinicki 2002). Indeed, several
lines of evidence suggest that telomere length is a
characteristic feature of human individuals/cells
(Takubo et al. 2002; Baird et al. 2003). The present
study further confirmed that telomere lengths in
individuals were distributed over a wide range in the
very early stage of life. On the other hand, data
demonstrating differential cell-specific telomere attri-
tion have been accumulated mainly through the use of
quantitative fluorescence in situ hybridization (Q-
FISH), the attrition rate showing variability even
within the hematopoietic lineage (Bearlocher et al.
2007; Aida et al. 2010). Although it is obvious that
both initial telomere length and attrition rate are the
most crucial factors for correct estimation of telomere
status, such fundamental data remain largely undeter-
mined. The telomere dynamics investigated in the
present study could constitute useful basic data for
studies of this issue, especially in the context of initial
telomere length.
In a previous study, we examined telomere length
dynamics (in the cerebrum) in relation to autopsy data
for the sample donors. The clinical data indicated a
decrease in the rate of cancer death in individuals in their
eighties and nineties relative to that for individuals in
their sixties, and a paucity of cancer death in individuals
in their eighties bearing long telomeres. On the basis of
the overall data, we hypothesized that longer telomeres
protected the genome from instability (a major cause of
carcinogenesis) and were associated with increased
longevity (Nakamura et al. 2007). This was the first
report to suggest a relationship between telomere
length and longevity in the context of the incidence
of cancer-related death (Kappei and Londoño-Vallejo
2007). In the present study, we again confirmed the
relationship between age and cancer death rate in the
cohort we analyzed. On the other hand, telomere
attrition is thought to be accelerated (or decelerated)
by various environmental or epigenetic factors, such as
oxidative stress (von Zglinicki et al. 1995), life stress
(Epel et al. 2004), or alcohol intake (Aida et al. 2011)
in a tissue/cell-specific manner, and telomere shorten-
ing may, in turn, trigger replicative senescence or
chromosomal instability, leading to age-related degen-
eration or tumorigenesis (Hastie et al. 1990; Vaziri et al.
1993; Nakamura et al. 2007). Therefore, it is possible
that individuals with longer telomeres are more likely
to have better tolerance to the degenerative effects of
aging. Unfortunately, we did not investigate TRF
lengths in cancer tissues in the present study and
therefore we were unable to compare them with the
TRF lengths for the pituitary in the same patient. Since
telomere dynamics in the pituitary show the highest
degree of conservation throughout life, our findings
provide indispensable fundamental data for future
studies of telomere dynamics in vivo, and for investi-
gating a number of still intriguing issues. Our findings
also lend support to the contention that longer telomeres
may exert a stronger protective effect against genome
instability or age-related diseases, and are correlated
with longevity.
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